Navigation Links
Medical Simulation Corporation to Introduce Central Line Management Program at the National Teaching Institute and Critical Care Exposition
Date:5/11/2009

Simulation-based program helps healthcare providers build competence and confidence while keeping infections at bay

DENVER, May 11 /PRNewswire/ -- Medical Simulation Corporation (MSC) will launch the SimSuite Central Line Management Program at AACN's National Teaching Institute (NTI) and Critical Care Exposition, the world's largest conference for nurses who care for acutely and critically ill patients, May 16-21, in New Orleans, LA. The Central Line Management Program is the latest offering in a full menu of MSC simulation-based curriculum that address national initiatives led by organizations, such as the Institute for Healthcare Improvement, Joint Commission, Leapfrog, CDC and Medicare, to track and improve patient safety and quality in the hospital setting.

Each year, an estimated 250,000 cases of central line-associated bloodstream infections (CLABSI) occur in hospitals in the United States. These potentially preventable infections are associated with an estimated mortality of 12 to 25 percent and an additional cost up to $56,000 per episode. MSC's comprehensive SimSuite Central Line Management Program brings together the best practices for central venous catheter insertion and management into a comprehensive program that increases the competence and confidence(R) of all healthcare team members.

"The SimSuite Central Line Management Program provides information on incidence, prevalence, epidemiology, and direct and indirect costs associated with central line associated bloodstream infections," says Julibeth Petter, PhD, ACNS-BC, ANCC Board Certified Clinical Nurse Specialist and SimSuite Central Line Management Program Author. "Providing this level of detail increases learners' understanding and motivates them to standardize and ac
'/>"/>

SOURCE Medical Simulation Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
2. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
3. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
4. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
5. BioMS Medical announces its intention to renew a normal course issuer bid
6. Dr. Amit Dhawan Promoted to Medical Director for The Mattson Jack Group
7. ATS Medical Expands Open Pivot Heart Valve Offerings
8. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
9. Globus Medical Announces Record 2nd Quarter 2007 Results
10. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
11. China Medical Technologies Reports First Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... (PRWEB) February 27, 2015 The ... system (Nexera UC) can sequentially analyze up to ... combined with high-sensitivity detection of targets by mass ... designed to fulfill the measurement requirements of a ... food products, drug delivery and search for disease ...
(Date:2/27/2015)... 2015 FamilyFarms Group is pleased to ... State Line Farms, received the 2015 Tomorrow’s Top Producer ... the age of 35, who has demonstrated excellence in ... to win the Tomorrow's Top Producer Horizon Award. Every ... Top Producer Award and learning from their experiences. It ...
(Date:2/27/2015)... PureTech , a science and technology R&D company focused  ... in the healthcare sector, announced today the appointment of ... the Board of Directors of Sanofi, to its Board ... pleasure to know Chris for many years and I ... more closely now," said Dr. Robert Langer , ...
(Date:2/26/2015)...  23andMe, the leading personal genetics company, today announced ... Officer and Corporate Counsel. Black brings a strong background ... as health care regulations. As a member of the ... reviewing, updating and enhancing the company,s privacy and consent ... joined the company January 5, 2015 and reports to ...
Breaking Biology Technology:Shimadzu Corporation Launches Nexera UC - The World’s Foremost Unified Chromatography System 2Shimadzu Corporation Launches Nexera UC - The World’s Foremost Unified Chromatography System 3Matt Sims Receives the 2015 Tomorrow’s Top Producer Horizon Award 2Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 2Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 3Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 423andMe Appoints Kate Black as Privacy Officer and Corporate Counsel 2
... it Possible for Employers to Hire Overseas Workers - ... Today,s outsourcing industry has taken a giant leap forward ... Systems ( http://www.cybracero.com ), which makes it possible ... the first-world countries without ever having to leave their ...
... for Samtheo,s Personalized Medicine PortfolioNEW YORK, March 16 ... license agreement, through its subsidiary, Lyndor Biosciences LLC, ... to a small molecule that selectively inhibits the ... activation of the Akt pathway has been found ...
... Call to be Held at 9:00 a.m. Eastern Time ... 16 United Therapeutics Corporation (Nasdaq: UTHR ... interactions with the U.S. Food and Drug Administration (FDA), ... Application (NDA) for Tyvaso(TM) (inhaled treprostinil) will likely extend ...
Cached Biology Technology:New Technology to Revolutionize the Way the Planet Does Business 2Samtheo Announces License Agreement with Moffitt Cancer Center for Exclusive Rights to Novel Akt Inhibitor 2Samtheo Announces License Agreement with Moffitt Cancer Center for Exclusive Rights to Novel Akt Inhibitor 3United Therapeutics Announces Probable Delay in Approval Timeline for Inhaled Treprostinil (Tyvaso) 2United Therapeutics Announces Probable Delay in Approval Timeline for Inhaled Treprostinil (Tyvaso) 3
(Date:2/5/2015)... , Jan. 28, 2015 Research and ... the addition of the "Global Biometrics Market ... Regions and Countries " report to their offering. ... Asia-Pacific is anticipated to ... 2015, owing to increasing government spending towards IT ...
(Date:1/22/2015)... CHICAGO , Jan. 9, 2015 Valid S.A. ("Company") ... the market in general the State of Washington,s ... contract for a new enrollment and central issuance system for ... The project planning and development will start ...
(Date:1/22/2015)... 2015  BellBrook Labs, a leader in high throughput ... of a TR-FRET (time resolved Forster resonance energy ... a high throughput screening assay for glycosyltransferases and ... for sensitive detection of hundreds of human and ...
Breaking Biology News(10 mins):Global Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, End Use, Regions and Countries 2Global Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, End Use, Regions and Countries 3Valid USA Signs Contract For Washington Driver's License Issuance 2BellBrook Labs Launches a High Throughput Screening Assay for Glycosyltransferases with TR-FRET Readout 2
... Elderly mice suffering from age-related heart disease saw a significant ... drug rapamycin for just three months. The research, led ... Research on Aging, shows how rapamycin impacts mammalian tissues, providing ... been shown to extend the lifespan of mice as much ...
... Scientists at Rice University and Oak Ridge National Laboratory ... a method to control the growth of uniform atomic layers ... of a trilogy of materials needed to make functioning 2-D ... manufacture of devices so small they would be invisible to ...
... part of the skeletal support for the membrane in ... Joanny from the Physico Chemistry Curie Unit at the ... a well-defined layer beneath the cell outer membrane forms ... motor proteins within the cellular system. These findings, which ...
Cached Biology News:Lifespan-extending drug given late in life reverses age-related heart disease in mice 22-D electronics take a step forward 22-D electronics take a step forward 3
... sets a new standard for high performance ... new design in instrumentation, this easy-to-use benchtop ... The BD FACSAria instrument is the first ... flow cell. This new flow cell ...
Mouse polyclonal antibody raised against a partial recombinant AGTRAP. NCBI Entrez Gene ID = 57085...
...
Mouse monoclonal antibody raised against a partial recombinant ZNF155. NCBI Entrez Gene ID = ZNF155...
Biology Products: